During therapy, some cancer cells evolve to escape elimination. Newer anticancer drugs that can overcome this resistance are necessary. Now, researchers from Japan demonstrate that aromatic ...

Regeneron Pharmaceuticals has won FDA accelerated approval of its Lynozyfic treatment for certain patients with the blood cancer multiple myeloma.

The idea that a prolonged interval between diagnosing and treating uveal melanoma can affect prognosis has been at the centre of an active debate.1–5 This issue focuses on a key question for ...

Sonodynamic therapy (SDT) is a promising noninvasive cancer treatment due to its superior tissue penetration depth compared to phototherapy. Herein, we developed a lysosome-targeted cyclometalated ...

Background Evidence on the role of very low or very high volumes of leisure time physical activity (PA) on the risk of all-cause and cause-specific mortality is limited. We aimed to examine the ...

Results 50 225 walkers were entered in the core analyses. Among participants who did not experience an event in the first 2 years of follow-up (n=49 731), walking at an average or brisk/fast pace was ...

A food beloved by Brits could not only raise your risk of dying younger but make you vulnerable to a whole host of deadly conditions, according to research. Eating this food regularly could increase ...